Androgen exposure and the maintenance of skeletal integrity in aging men

Aging Male

Volumn 1, Issue 3, 1998, Pages 180-187

  Vanderschueren, D ^a,b   Boonen, S ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Androgens; Dihydrotestosterone; Men; Osteoporosis; Rat; Testosterone

Indexed keywords

EID: 0001521849     PISSN: 13685538     EISSN: None     Source Type: Journal    
DOI: 10.3109/13685539809146106     Document Type: Review

References (59)

1. Riggs B, Khosla S, Melton J. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998;13:763-73
2. Colvard D, Eriksen E, Keeting P, Wilson E, Lubahn D, French F, et al. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci 1989;86:854-7
3. Orwoll E, Stribrska L, Ramsey E, Keenan E. Androgen receptors in osteoblast-like cells. Calcif Tissue Int 1991;49:183-7
4. Benz D, Haussler M, Thomas M, Speelman B, Komm B. High-affinity androgen binding and androgenic regulation of alfa1(I)-procollagen and transforming growth factor-β steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology 1991;128: 2723-30
5. Masuyama A, Ouchi Y, Sato F, Hosoi T, Nakamura T, Orimo H. Characteristics of steroid hormone receptors in cultured LC3T3-E1 osteoblastic cells and effect of steroid hormones on cell proliferation. Calcif Tissue Int 1992;51:376-81
6. Abu E, Horner A, Kusec V, Triffitt J, Compston J. The localization of androgen receptors in human bone. J Clin Endocrinol Metab 1997;82:3493-7
7. Eriksen E, Colvard D, Berg N, Graham M, Mann K, Spelsberg T, et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988;241:84-6
8. Bruch H, Wolf L, Budde R, Romalo G, Schweikert H. Androstenedione metabolism in cultured human osteoblast-like cells. J Clin Endocrinol Metab 1992;75:101-5
9. Tanaka S, Haji M, Nishi Y, Yanase T, Takayanagi R, Nawata H. Aromatase activity in human osteoblast-like osteosarcoma cell. Calcif Tissue Int 1993;52:107-9
10. Purohit A, Flanagan A, Reed M. Estrogen synthesis by osteoblast cell lines. J Clin Endocrinol Metab 1992; 61:152-7
11. Kasperk C, Wergedal J, Farley J, Linkhart T, Turner R, Baylink D. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 1989;124:1576-9
12. Gray C, Colston K, MacKay A, Taylor L, Arnett T. Interaction of androgen and 1,25-dihydroxyvitamin D3: effects on normal rat bone cells. J Bone Miner Res 1989;7:41-6
13. Weisman Y, Cassorla F, Malozowski S, Krieg R, Goldray D, Kaye A, et al. Sex-specific response of bone cells to gonadal steroids: modulation in perinatally androgenized females and in testicular feminized male rats. Steroids 1993;58:126-33
14. Kasperk C, Fitzsimmons R, Strong D, Mohan S, Jennings J, Wergedal J, et al. Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab 1990;71:1322-9
15. Bellido T, Girasole G, Jilka R, Crabb D, Manolagas S. Demonstration of androgen receptors in bone marrow stromal cells and their role in the regulation of transcription from the human interleukin-6 (IL-6) gene promotor. J Bone Miner Res 1993;8 (Suppl 1):57
16. Ryaby J, Magee F, Khin N, Fitzsimmons R, Baylink D. Downregulation of osteoclastogenic potential in vivo by combined ac/dc magnetic fields. J Bone Miner Res 1993;8(Suppl 1):626
17. Girasole G, Jilka R, Passeri G, Scott B, Boder G, Williams D, et al. Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro. A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992;89:883-91
18. Pilbeam C, Raisz L. Effects of androgens on parathyroid and interleukin-I-stimulated prostaglandin production in cultured neonatal mouse calvariae. J Bone Miner Res 1990;5:1183-8
19. Fukayama S, Tashjan A. Direct modulation by androgens of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTRrp. Endocrinology 1989;125:1789-94
20. Jilka R, Weinstein R, Takahashi K, Parfitt A, Manolagas S. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 1996;97: 1732-40
21. Weinstein R, Jilka R, Parfitt A, Manolagas S. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. Endocrinology 1997;138:4013-22
22. Schoutens A, Verhas M, L'Hermite-Baleriaux, L'Hermite M, Verschaeren A, Dourov N, et al. Growth and bone haemodynamic responses to castration in male rats. Reversibility by testosterone. Acta Endocrinol 1984;107:428-32
23. Wakley G, Schritte H, Kathleen S, Turner R. Androgen treatment prevents loss of cancellous bone in the orchidectomized rat. J Bone Miner Res 1991;6:325-30
24. Saville P. Changes in skeletal mass and fragility with castration in the rat: a model for osteoporosis. Am Geriatr Soc 1969;17:155-66
25. Hock J, Fonseca J, Gunness-Hey, Kemp B, Martin T. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrp)-34 and PTHI-34 on bone in rats. Endocrinology 1989;125:2022-7
26. Turner R, Hannon K, Demers L, Buchanan J, Bell N. Differential effects of gonadal function on bone histomorphometry in male and female rats. J Bone Miner Res 1989;4:557-63
27. Turner R, Wakley G, Hannon K. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J Orthop Res 1990;8:612-17
28. Vanderschueren D, Van Herck E, Suiker A, Visser W, Schot L, Bouillon R. Bone and mineral metabolism in aged male rats: short- and long-term effects of androgen deficiency. Endocrinology 1992;130: 2906-16
29. Wink C, Felts W. Effects of castration on the bone structure of male rats: a model for osteoporosis. Calcif Tissue Int 1980;32:77-82
30. Verhas M, Schoutens A, L'Hermite-Baleriaux, Dourov N, Verschaeren A, Mone M, et al. The effect of orchidectomy on bone metabolism in aging rats. Calcif Tissue Int 1986;39:74-7
31. Danielson C, Mosekilde L, Andreassen T. Long-term effect of orchidectomy on cortical bone from rat femur bone mass and mechanical properties. Calcif Tissue Int 1992;50:169-74
32. Wink C. A scanning electronic-microscopic study of femoral bone surfaces from castrate rats treated with dichloromethylene biphosphonate. Acta Anat 1986;126:57-62
33. Vanderschueren D, Van Herck E, Schot L, Rush E, Einhorn T, Geusens P, et al. The aged male rat as a model for human osteoporosis: evaluation by nondestructive measurements and biomechanical testing. Calcif Tissue Int 1993;53:342-7
34. Hodgkinson A. Effects of calcium deprivation and orchidectomy on bone composition in the rat. Horm Metab Res 1979;11:516-19
35. Gürkan L, Ekeland A, Gautvik K, Langeland N, Ronningen H, Solheim L. Bone changes after castration in rats. Acta Orthop Scand 1986;57: 67-70
36. Chow J, Badve S, Chambers T. A comparison of microanatomic basis for coupling between bone formation and bone resorption in man and the rat. Bone 1993;14:355-60B
37. Vanderschueren D, Van Herck E, Nijs J, Ederveen A, De Coster R, Bouillon R. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology 1997;138:2301-7
38. Kalu D, Hardin R, Cockerman R. Evaluation of the pathogenesis of skeletal changes in ovariectomized rats. Endocrinology 1984;115:507-12
39. Orwoll E, Klein R. Osteoporosis in men. Endocr Rec 1995;16:87-116
40. Gray A, Feldman H, McKinlay J, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J Clin Endocrinol Metab 1991;73: 1016-25
41. Abassi A, Drinka P, Mattson D, Rudman D. Low circulating levels of insulin-like growth factors and testosterone in chronically institutionalized elderly men. J Am Geriatr Soc 1993;41:975-82
42. Vermeulen A. Androgens in the aging male. J Clin Endocrinol Metab 1991;73:221-4
43. Kaufman JM, Vermeulen A. Androgens in male senescence. In Nieschlag E, Behre HM, eds. Testosterone: Action, Deficiency, Substitution, 2nd edn. Berlin, Heidelberg: Springer-Verlag, 1998;16: 437-71
44. Finkelstein J, Klibanski A, Neer R, Greenspan S, Rosenthal D, Crowley W. Osteoporosis in men with idiopathic hypogonadotropic hypogonadis. Ann Intern Med 1987;106:354-61
45. Greenspan S, Oppenheim S, Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 1989;110:526-31
46. Boonen S, Vanderschueren D, Geusens P, Bouillon R. Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men. Int J Androl 1997;20:134-43
47. Greendale G, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res 1997;12:1833-43
48. Cooper C, Campion G, Melton L. Hip fractures in the elderly: a world-wide projection. Osteoporosis Int 1992;2:285-9
49. Poor G, Atkinson E, O'Fallon W, Melton L. Prediction of hip fractures in elderly men. J Bone Miner Res 1995;10:1900-7
50. Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991;39:766-71
51. Jackson J, Riggs M, Spiekerman A. Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 1992;304:4-8
52. Boonen S, Vanderschueren D, Cheng X, Verbeke G, Dequeker J, Geusens P, et al. Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption. J Bone Miner Res 1997;12:2119-26
53. Diamond T, Stiel D, Posen S. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Done Miner Res 1991;6:39-43
54. Devogelaer JP, Decooman S, Dedeuxchaines C. Low bone mass in hypogonadal males. Maturitas 1992;15:17-21
55. Isaia G, Mussetta M, Pecchio F, Sciolla A, Distefano M, Molinatti G. Effect of testosterone on bone in hypogonadal males. Maturitas 1992;15: 47-51
56. Wang C, Eyre DR, Clark R, Kleinberg D, Newman C, Iranmanesh A, et al. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men - a clinical research center study. J Clin Endocrinol Metab 1996;81:3654-62
57. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996;81:4358-65
58. Nieschlag E, Behre HM. Testosterone therapy. In Nieschlag E, Behre HM, eds. Andrology - Male Reproductive Health and Dysfunction. Berlin, Heidelberg, New York: Springer, 1997;295-308
59. Tenover J. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992;75: 1092-8